Tiziana Life Sciences Ltd (NASDAQ:TLSA) Short Interest Update

Tiziana Life Sciences Ltd (NASDAQ:TLSA) was the recipient of a significant decline in short interest in September. As of September 15th, there was short interest totalling 41,900 shares, a decline of 67.0% from the August 31st total of 127,100 shares. Based on an average daily trading volume, of 266,900 shares, the days-to-cover ratio is presently 0.2 days.

Tiziana Life Sciences Stock Up 1.0 %

Shares of TLSA traded up $0.01 during midday trading on Wednesday, hitting $0.93. 18,979 shares of the company traded hands, compared to its average volume of 197,862. The firm has a 50 day moving average of $1.05 and a 200-day moving average of $0.83. Tiziana Life Sciences has a 52 week low of $0.41 and a 52 week high of $1.74.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.